Erman Öztürk

10PUBLICATIONS
116CO-AUTHORS
HaematologyPharmacogenomicsHaematological tumoursPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 04, 2023
High-density lipoprotein (HDL) has an impact on myeloma outcome: Lower HDL associates with worse progression-free survival.

Işıl Erdoğan Özünal, Emrah Kılıçaslan, Tayfun Elibol

|Feb 27, 2023
Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?

Ilgın Koçak Göktürk, Işıl Erdoğan Özünal, Alican Göktürk

|Jun 09, 2022
Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)

Ömür Kayıkçı, Özgür Mehtap, İsmail Sarı

|May 18, 2022
Transcriptomic analysis of asymptomatic and symptomatic severe Turkish patients in SARS-CoV-2 infection.

Sadrettin Pence, Burcu Caykara, Halime Hanim Pence

|Mar 21, 2022
Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma.

Erman Ozturk, Tayfun Elibol, Emrah Kilicaslan

|Oct 20, 2021
Are Hematologic Patients Trojan Horse for COVID-19?

Emrah Kılıçaslan, Işıl Erdoğan Özünal, Tayfun Elibol

Pageof 2